{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T18:21:10Z","timestamp":1792261270215,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-024-01554-6","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T06:48:57Z","timestamp":1731998937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chiglitazar ameliorates dehydroepiandrosterone-induced polycystic ovary syndrome in rats"],"prefix":"10.1186","volume":"17","author":[{"given":"Fuzhen","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengmei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"1554_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.beem.2018.03.008","volume":"32","author":"KA Walters","year":"2018","unstructured":"Walters KA, Bertoldo MJ, Handelsman DJ. Evidence from animal models on the pathogenesis of PCOS. Best Pract Res Clin Endocrinol Metab. 2018;32:271\u201381.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1554_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/TACG.S200341","volume":"12","author":"MJ Khan","year":"2019","unstructured":"Khan MJ, Ullah A, Basit S. Genetic basis of Polycystic Ovary Syndrome (PCOS): current perspectives. Appl Clin Genet. 2019;12:249\u201360.","journal-title":"Appl Clin Genet."},{"key":"1554_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BCJM Fauser","year":"2012","unstructured":"Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97:28-38.e25.","journal-title":"Fertil Steril"},{"key":"1554_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/13813455.2018.1499120","volume":"126","author":"DM Bannigida","year":"2020","unstructured":"Bannigida DM, Nayak BS, Vijayaraghavan R. Insulin resistance and oxidative marker in women with PCOS. Arch Physiol Biochem. 2020;126:183\u20136.","journal-title":"Arch Physiol Biochem"},{"key":"1554_CR5","doi-asserted-by":"publisher","first-page":"100011","DOI":"10.1016\/j.prmcm.2021.100011","volume":"1","author":"M Joshi","year":"2021","unstructured":"Joshi M, Shankar R, Pathak K, Yadav R. Polycystic ovarian syndrome: a review covering phytoconstituents for its outstrip management. Pharmacol Res - Modern Chin Med. 2021;1:100011.","journal-title":"Pharmacol Res - Modern Chin Med"},{"key":"1554_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.fertnstert.2015.01.019","volume":"103","author":"W Vitek","year":"2015","unstructured":"Vitek W, Alur S, Hoeger KM. Off-label drug use in the treatment of polycystic ovary syndrome. Fertil Steril. 2015;103:605\u201311.","journal-title":"Fertil Steril"},{"key":"1554_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/sj.bjp.0706745","volume":"148","author":"P-P Li","year":"2006","unstructured":"Li P-P, Shan S, Chen Y-T, Ning Z-Q, Sun S-J, Liu Q, et al. The PPARalpha\/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats. Br J Pharmacol. 2006;148:610\u20138.","journal-title":"Br J Pharmacol"},{"key":"1554_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2024.112337","volume":"593","author":"L Liu","year":"2024","unstructured":"Liu L, Sun W, Tang X, Zhen D, Guan C, Fu S, et al. Chiglitazar attenuates high-fat diet-induced nonalcoholic fatty liver disease by modulating multiple pathways in mice. Mol Cell Endocrinol. 2024;593: 112337.","journal-title":"Mol Cell Endocrinol"},{"key":"1554_CR9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4103\/2231-4040.90879","volume":"2","author":"S Tyagi","year":"2011","unstructured":"Tyagi S, Gupta P, Saini AS, Kaushal C, Sharma S. The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases. J Adv Pharm Technol Res. 2011;2:236\u201340.","journal-title":"J Adv Pharm Technol Res"},{"key":"1554_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s10020-023-00740-4","volume":"29","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Xu J, Zhou D, Ye T, Zhou P, Liu Z, et al. Swimming exercise ameliorates insulin resistance and nonalcoholic fatty liver by negatively regulating PPAR\u03b3 transcriptional network in mice fed high fat diet. Mol Med. 2023;29:150.","journal-title":"Mol Med"},{"key":"1554_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1161\/CIRCRESAHA.110.221713","volume":"107","author":"NH Banke","year":"2010","unstructured":"Banke NH, Wende AR, Leone TC, O\u2019Donnell JM, Abel ED, Kelly DP, et al. Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARalpha. Circ Res. 2010;107:233\u201341.","journal-title":"Circ Res"},{"key":"1554_CR12","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.2337\/diabetes.52.9.2331","volume":"52","author":"EH Koh","year":"2003","unstructured":"Koh EH, Kim M-S, Park J-Y, Kim HS, Youn J-Y, Park H-S, et al. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation. Diabetes. 2003;52:2331\u20137.","journal-title":"Diabetes"},{"key":"1554_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.diabet.2019.05.005","volume":"46","author":"S Smati","year":"2020","unstructured":"Smati S, R\u00e9gnier M, Fougeray T, Polizzi A, Fougerat A, Lasserre F, et al. Regulation of hepatokine gene expression in response to fasting and feeding: influence of PPAR-\u03b1 and insulin-dependent signalling in hepatocytes. Diabetes Metab. 2020;46:129\u201336.","journal-title":"Diabetes Metab"},{"key":"1554_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40659-023-00441-6","volume":"56","author":"X Chen","year":"2023","unstructured":"Chen X, He H, Long B, Wei B, Yang P, Huang X, et al. Acupuncture regulates the apoptosis of ovarian granulosa cells in polycystic ovarian syndrome-related abnormal follicular development through LncMEG3-mediated inhibition of miR-21-3p. Biol Res. 2023;56:31.","journal-title":"Biol Res"},{"key":"1554_CR15","doi-asserted-by":"publisher","first-page":"bnaa010","DOI":"10.1210\/endrev\/bnaa010","volume":"41","author":"E Stener-Victorin","year":"2020","unstructured":"Stener-Victorin E, Padmanabhan V, Walters KA, Campbell RE, Benrick A, Giacobini P, et al. Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr Rev. 2020;41:bnaa010.","journal-title":"Endocr Rev"},{"key":"1554_CR16","first-page":"3286","volume":"22","author":"Y-C Jiang","year":"2018","unstructured":"Jiang Y-C, Ma J-X. The role of MiR-324-3p in polycystic ovary syndrome (PCOS) via targeting WNT2B. Eur Rev Med Pharmacol Sci. 2018;22:3286\u201393.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"1554_CR17","first-page":"2120","volume":"15","author":"Y Wu","year":"2018","unstructured":"Wu Y, Li P, Zhang D, Sun Y. Metformin and pioglitazone combination therapy ameliorate polycystic ovary syndrome through AMPK\/PI3K\/JNK pathway. Exp Ther Med. 2018;15:2120\u20137.","journal-title":"Exp Ther Med"},{"key":"1554_CR18","doi-asserted-by":"publisher","first-page":"113540","DOI":"10.1016\/j.jep.2020.113540","volume":"267","author":"U Suriyakalaa","year":"2021","unstructured":"Suriyakalaa U, Ramachandran R, Doulathunnisa JA, Aseervatham SB, Sankarganesh D, Kamalakkannan S, et al. Upregulation of Cyp19a1 and PPAR-\u03b3 in ovarian steroidogenic pathway by Ficus religiosa: a potential cure for polycystic ovary syndrome. J Ethnopharmacol. 2021;267:113540.","journal-title":"J Ethnopharmacol"},{"key":"1554_CR19","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s43032-024-01503-0","volume":"31","author":"S Ji","year":"2024","unstructured":"Ji S, Yang H, Ji Y, Wu W, Dong Y, Fu H, et al. Liraglutide improves PCOS symptoms in rats by Targeting FDX1. Reprod Sci. 2024;31:2049\u201358.","journal-title":"Reprod Sci"},{"key":"1554_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molmed.2023.02.006","volume":"29","author":"L Ib\u00e1\u00f1ez","year":"2023","unstructured":"Ib\u00e1\u00f1ez L, de Zegher F. Adolescent PCOS: a postpubertal central obesity syndrome. Trends Mol Med. 2023;29:354\u201363.","journal-title":"Trends Mol Med"},{"key":"1554_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.psyneuen.2018.01.007","volume":"89","author":"B Misiak","year":"2018","unstructured":"Misiak B, Frydecka D, Loska O, Moustafa AA, Samochowiec J, Kasznia J, et al. Testosterone, DHEA and DHEA-S in patients with schizophrenia: a systematic review and meta-analysis. Psychoneuroendocrinology. 2018;89:92\u2013102.","journal-title":"Psychoneuroendocrinology"},{"key":"1554_CR22","first-page":"2248","volume":"82","author":"AE Taylor","year":"1997","unstructured":"Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82:2248\u201356.","journal-title":"J Clin Endocrinol Metab"},{"key":"1554_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37:467\u2013520.","journal-title":"Endocr Rev"},{"key":"1554_CR24","first-page":"707","volume":"15","author":"AJ Hsueh","year":"1994","unstructured":"Hsueh AJ, Billig H, Tsafriri A. Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev. 1994;15:707\u201324.","journal-title":"Endocr Rev"},{"key":"1554_CR25","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","volume":"105","author":"LME Moolhuijsen","year":"2020","unstructured":"Moolhuijsen LME, Visser JA. Anti-m\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab. 2020;105:3361\u201373.","journal-title":"J Clin Endocrinol Metab"},{"key":"1554_CR26","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1210\/me.2013-1233","volume":"27","author":"H-M Chang","year":"2013","unstructured":"Chang H-M, Cheng J-C, Klausen C, Leung PCK. BMP15 suppresses progesterone production by down-regulating StAR via ALK3 in human granulosa cells. Mol Endocrinol. 2013;27:2093\u2013104.","journal-title":"Mol Endocrinol"},{"key":"1554_CR27","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.metabol.2009.02.022","volume":"58","author":"F Gonz\u00e1lez","year":"2009","unstructured":"Gonz\u00e1lez F, Rote NS, Minium J, Kirwan JP. Evidence of proatherogenic inflammation in polycystic ovary syndrome. Metabolism. 2009;58:954\u201362.","journal-title":"Metabolism"},{"key":"1554_CR28","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1210\/clinem\/dgac176","volume":"107","author":"W Zhou","year":"2022","unstructured":"Zhou W, Li S, Sun G, Song L, Feng W, Li R, et al. Early Warning of Ischemic Stroke Based on Atherosclerosis Index Combined With Serum Markers. J Clin Endocrinol Metab. 2022;107:1956\u201364.","journal-title":"J Clin Endocrinol Metab"},{"issue":"e142241","key":"1554_CR29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142241","volume":"131","author":"AR Saltiel","year":"2021","unstructured":"Saltiel AR. Insulin signaling in health and disease. J Clin Invest. 2021;131(e142241): 142241.","journal-title":"J Clin Invest"},{"key":"1554_CR30","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/35055575","volume":"409","author":"ED Abel","year":"2001","unstructured":"Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 2001;409:729\u201333.","journal-title":"Nature"},{"key":"1554_CR31","doi-asserted-by":"publisher","first-page":"37803","DOI":"10.1074\/jbc.M503897200","volume":"280","author":"M Larance","year":"2005","unstructured":"Larance M, Ramm G, St\u00f6ckli J, van Dam EM, Winata S, Wasinger V, et al. Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking. J Biol Chem. 2005;280:37803\u201313.","journal-title":"J Biol Chem"},{"key":"1554_CR32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1530\/EJE-07-0857","volume":"158","author":"M Jensterle","year":"2008","unstructured":"Jensterle M, Janez A, Mlinar B, Marc J, Prezelj J, Pfeifer M. Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome. Eur J Endocrinol. 2008;158:793\u2013801.","journal-title":"Eur J Endocrinol"},{"key":"1554_CR33","doi-asserted-by":"publisher","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","volume":"106","author":"KM Hoeger","year":"2021","unstructured":"Hoeger KM, Dokras A, Piltonen T. Update on PCOS: consequences, challenges, and guiding treatment. J Clin Endocrinol Metab. 2021;106:e1071-83.","journal-title":"J Clin Endocrinol Metab"},{"key":"1554_CR34","doi-asserted-by":"publisher","first-page":"103821","DOI":"10.1016\/j.drudis.2023.103821","volume":"28","author":"S Kulkarni","year":"2023","unstructured":"Kulkarni S, Gupta K, Ratre P, Mishra PK, Singh Y, Biharee A, et al. Polycystic ovary syndrome: current scenario and future insights. Drug Discovery Today. 2023;28:103821.","journal-title":"Drug Discovery Today"},{"key":"1554_CR35","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1097\/CM9.0000000000001712","volume":"134","author":"R-L Ma","year":"2021","unstructured":"Ma R-L, Deng Y, Wang Y-F, Zhu S-Y, Ding X-S, Sun A-J. Short-term combined treatment with exenatide and metformin for overweight\/obese women with polycystic ovary syndrome. Chin Med J (Engl). 2021;134:2882\u20139.","journal-title":"Chin Med J (Engl)"},{"key":"1554_CR36","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.3390\/ijms20205055","volume":"20","author":"HS Cheng","year":"2019","unstructured":"Cheng HS, Tan WR, Low ZS, Marvalim C, Lee JYH, Tan NS. Exploration and development of PPAR modulators in health and disease: an update of clinical evidence. Int J Mol Sci. 2019;20:5055.","journal-title":"Int J Mol Sci"},{"key":"1554_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrendo.2016.135","volume":"13","author":"B Gross","year":"2017","unstructured":"Gross B, Pawlak M, Lefebvre P, Staels B. PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD. Nat Rev Endocrinol. 2017;13:36\u201349.","journal-title":"Nat Rev Endocrinol"},{"key":"1554_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1677\/joe.1.06667","volume":"189","author":"P Froment","year":"2006","unstructured":"Froment P, Gizard F, Defever D, Staels B, Dupont J, Monget P. Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition. J Endocrinol. 2006;189:199\u2013209.","journal-title":"J Endocrinol"},{"key":"1554_CR39","doi-asserted-by":"publisher","first-page":"176275","DOI":"10.1155\/2008\/176275","volume":"2008","author":"J Dupont","year":"2008","unstructured":"Dupont J, Chabrolle C, Ram\u00e9 C, Tosca L, Coyral-Castel S. Role of the peroxisome proliferator-activated receptors, adenosine monophosphate-activated kinase, and adiponectin in the ovary. PPAR Res. 2008;2008:176275.","journal-title":"PPAR Res"},{"key":"1554_CR40","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1210\/er.2003-0004","volume":"24","author":"RS Legro","year":"2003","unstructured":"Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev. 2003;24:302\u201312.","journal-title":"Endocr Rev"},{"key":"1554_CR41","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33:981\u20131030.","journal-title":"Endocr Rev"},{"key":"1554_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40265-021-01648-1","volume":"82","author":"ED Deeks","year":"2022","unstructured":"Deeks ED. Chiglitazar: first approval. Drugs. 2022;82:87\u201392.","journal-title":"Drugs"},{"key":"1554_CR43","doi-asserted-by":"publisher","first-page":"119133","DOI":"10.1016\/j.lfs.2021.119133","volume":"270","author":"H Tang","year":"2021","unstructured":"Tang H, Zeng Q, Tang T, Wei Y, Pu P. Kaempferide improves glycolipid metabolism disorder by activating PPAR\u03b3 in high-fat-diet-fed mice. Life Sci. 2021;270:119133.","journal-title":"Life Sci"},{"key":"1554_CR44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1095\/biolreprod66.1.190","volume":"66","author":"PD Schoppee","year":"2002","unstructured":"Schoppee PD, Garmey JC, Veldhuis JD. Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. Biol Reprod. 2002;66:190\u20138.","journal-title":"Biol Reprod"},{"key":"1554_CR45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1677\/JOE-08-0397","volume":"200","author":"AB Ropero","year":"2009","unstructured":"Ropero AB, Juan-Pic\u00f3 P, Rafacho A, Fuentes E, Berm\u00fadez-Silva FJ, Roche E, et al. Rapid non-genomic regulation of Ca2+ signals and insulin secretion by PPAR alpha ligands in mouse pancreatic islets of Langerhans. J Endocrinol. 2009;200:127\u201338.","journal-title":"J Endocrinol"},{"key":"1554_CR46","first-page":"1","volume":"50","author":"TW Jung","year":"2018","unstructured":"Jung TW, Lee SH, Kim H-C, Bang JS, Abd El-Aty AM, Hac\u0131m\u00fcft\u00fco\u011flu A, et al. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPAR\u03b4-dependent pathways in skeletal muscle of mice. Exp Mol Med. 2018;50:1\u201311.","journal-title":"Exp Mol Med"},{"key":"1554_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.88","volume":"6","author":"L Li","year":"2015","unstructured":"Li L, Li T, Zhang Y, Pan Z, Wu B, Huang X, et al. Peroxisome proliferator-activated receptor\u03b2\/\u03b4 activation is essential for modulating p-Foxo1\/Foxo1 status in functional insulin-positive cell differentiation. Cell Death Dis. 2015;6: e1715.","journal-title":"Cell Death Dis"},{"key":"1554_CR48","doi-asserted-by":"publisher","first-page":"117251","DOI":"10.1016\/j.jep.2023.117251","volume":"319","author":"Y-Y Yang","year":"2024","unstructured":"Yang Y-Y, Qi J-J, Jiang S-Y, Ye L. Esculin ameliorates obesity-induced insulin resistance by improving adipose tissue remodeling and activating the IRS1\/PI3K\/AKT\/GLUT4 pathway. J Ethnopharmacol. 2024;319:117251.","journal-title":"J Ethnopharmacol"},{"key":"1554_CR49","doi-asserted-by":"publisher","first-page":"658913","DOI":"10.1155\/2014\/658913","volume":"2014","author":"E Nigro","year":"2014","unstructured":"Nigro E, Scudiero O, Monaco ML, Palmieri A, Mazzarella G, Costagliola C, et al. New insight into adiponectin role in obesity and obesity-related diseases. Biomed Res Int. 2014;2014:658913.","journal-title":"Biomed Res Int"},{"key":"1554_CR50","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bbrc.2017.05.076","volume":"488","author":"A Singh","year":"2017","unstructured":"Singh A, Bora P, Krishna A. Direct action of adiponectin ameliorates increased androgen synthesis and reduces insulin receptor expression in the polycystic ovary. Biochem Biophys Res Commun. 2017;488:509\u201315.","journal-title":"Biochem Biophys Res Commun"},{"key":"1554_CR51","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1073\/pnas.1523236113","volume":"113","author":"X Yuan","year":"2016","unstructured":"Yuan X, Hu T, Zhao H, Huang Y, Ye R, Lin J, et al. Brown adipose tissue transplantation ameliorates polycystic ovary syndrome. Proc Natl Acad Sci U S A. 2016;113:2708\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1554_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/sj.ijo.0803719","volume":"32","author":"DB Campos","year":"2008","unstructured":"Campos DB, Palin M-F, Bordignon V, Murphy BD. The \u201cbeneficial\u201d adipokines in reproduction and fertility. Int J Obes (Lond). 2008;32:223\u201331.","journal-title":"Int J Obes (Lond)"},{"key":"1554_CR53","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1007\/s10815-023-02900-1","volume":"40","author":"P Hazrati","year":"2023","unstructured":"Hazrati P, Ramezani M, Ahmadimoghaddam D, Asl SS, Artimani T. The effects of AdipoRon on cytochrome P450-related gene expression, acute steroidogenic regulatory protein, and structure of ovary in polycystic ovary syndrome model. J Assist Reprod Genet. 2023;40:2453\u201361.","journal-title":"J Assist Reprod Genet"},{"key":"1554_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13048-018-0395-y","volume":"11","author":"M Morishita","year":"2018","unstructured":"Morishita M, Endo T, Baba T, Kuno Y, Ikeda K, Kiya T, et al. Pioglitazone is effective for multiple phenotyepes of the Zucker fa\/fa rat with polycystc ovary morphology and insulin resistance. J Ovarian Res. 2018;11:24.","journal-title":"J Ovarian Res"},{"key":"1554_CR55","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.metabol.2005.02.016","volume":"54","author":"F Oana","year":"2005","unstructured":"Oana F, Takeda H, Hayakawa K, Matsuzawa A, Akahane S, Isaji M, et al. Physiological difference between obese (fa\/fa) Zucker rats and lean Zucker rats concerning adiponectin. Metabolism. 2005;54:995\u20131001.","journal-title":"Metabolism"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01554-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-024-01554-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-024-01554-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T19:02:20Z","timestamp":1732042940000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-024-01554-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1554"],"URL":"https:\/\/doi.org\/10.1186\/s13048-024-01554-6","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"229"}}